Table: Sapporo Clinical Lab -2018/19 group results

Sapporo Clinical Laboratory

13/05/2019 07:30

May 13 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.07           17.46          17.40         8.44    
               (-2.3 pct)      (+2.4 pct)     (+2.0 pct)    (+0.0 pct) 
  Operating      815 mln           1.02         824 mln      347 mln   
               (-19.8 pct)     (+31.8 pct)    (+1.1 pct)    (+9.1 pct) 
  Recurring      813 mln           1.05         845 mln      357 mln   
               (-22.8 pct)     (+31.0 pct)    (+4.0 pct)    (+8.2 pct) 
  Net
  Net            523 mln         685 mln        552 mln      232 mln   
               (-23.6 pct)     (+33.4 pct)    (+5.6 pct)   (+12.3 pct) 
  EPS          152.42 yen      197.03 yen     161.45 yen    67.84 yen  
  Ann Div       10.00 yen       11.00 yen      10.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       10.00 yen       11.00 yen      10.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T